Literature DB >> 17148699

Chagas disease.

A R L Teixeira1, N Nitz, M C Guimaro, C Gomes, C A Santos-Buch.   

Abstract

Chagas disease is the clinical condition triggered by infection with the protozoan Trypanosoma cruzi. The infection is transmitted by triatomine insects while blood feeding on a human host. Field studies predict that one third of an estimated 18 million T cruzi-infected humans in Latin America will die of Chagas disease. Acute infections are usually asymptomatic, but the ensuing chronic T cruzi infections have been associated with high ratios of morbidity and mortality: Chagas heart disease leads to unexpected death in 37.5% of patients, 58% develop heart failure and die and megacolon or megaoesophagus has been associated with death in 4.5%. The pathogenesis of Chagas disease appears to be related to a parasite-induced mutation of the vertebrate genome. Currently, treatment is unsatisfactory.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17148699      PMCID: PMC2653922          DOI: 10.1136/pgmj.2006.047357

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  83 in total

Review 1.  Indeterminate form of Chagas disease.

Authors:  V Macêdo
Journal:  Mem Inst Oswaldo Cruz       Date:  1999       Impact factor: 2.743

2.  [Epidemiological surveillance of Chagas disease].

Authors:  J C Dias
Journal:  Cad Saude Publica       Date:  2000       Impact factor: 1.632

3.  Serologic and parasitologic demonstration of Trypanosoma cruzi infections in an urban area of central Mexico: correlation with electrocardiographic alterations.

Authors:  H Rangel-Flores; B Sánchez; J Mendoza-Duarte; C Barnabé; F S Brenière; C Ramos; B Espinoza
Journal:  Am J Trop Med Hyg       Date:  2001-12       Impact factor: 2.345

4.  Host-cell attachment by Trypanosoma cruzi: identification of an adhesion molecule.

Authors:  M F Lima; F Villalta
Journal:  Biochem Biophys Res Commun       Date:  1988-08-30       Impact factor: 3.575

5.  Women and congenital Chagas' disease in Santa Cruz, Bolivia: epidemiological and sociocultural aspects.

Authors:  E Azogue
Journal:  Soc Sci Med       Date:  1993-08       Impact factor: 4.634

6.  [Risk of Chagas disease through transfusions in the Americans].

Authors:  G A Schmuñis
Journal:  Medicina (B Aires)       Date:  1999       Impact factor: 0.653

Review 7.  The impact of HIV infection on tropical diseases.

Authors:  Gundel Harms; Hermann Feldmeier
Journal:  Infect Dis Clin North Am       Date:  2005-03       Impact factor: 5.982

8.  Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection.

Authors:  A L de Andrade; F Zicker; R M de Oliveira; S Almeida Silva; A Luquetti; L R Travassos; I C Almeida; S S de Andrade; J G de Andrade; C M Martelli
Journal:  Lancet       Date:  1996-11-23       Impact factor: 79.321

9.  Mutagenicity of nitro-azabenzo[a]pyrene and its related compounds.

Authors:  N Sera; K Fukuhara; N Miyata; K Horikawa; H Tokiwa
Journal:  Mutat Res       Date:  1992-08       Impact factor: 2.433

10.  A 9,000-year record of Chagas' disease.

Authors:  Arthur C Aufderheide; Wilmar Salo; Michael Madden; John Streitz; Jane Buikstra; Felipe Guhl; Bernardo Arriaza; Colleen Renier; Lorentz E Wittmers; Gino Fornaciari; Marvin Allison
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-06       Impact factor: 11.205

View more
  43 in total

1.  Arylimidamide DB766, a potential chemotherapeutic candidate for Chagas' disease treatment.

Authors:  Denise da Gama Jaén Batista; Marcos Meuser Batista; Gabriel Melo de Oliveira; Patrícia Borges do Amaral; Joseli Lannes-Vieira; Constança Carvalho Britto; Angela Junqueira; Marli Maria Lima; Alvaro José Romanha; Policarpo Ademar Sales Junior; Chad E Stephens; David W Boykin; Maria de Nazaré Correia Soeiro
Journal:  Antimicrob Agents Chemother       Date:  2010-05-10       Impact factor: 5.191

Review 2.  Recent progress in histochemistry and cell biology.

Authors:  Stefan Hübner; Athina Efthymiadis
Journal:  Histochem Cell Biol       Date:  2012-02-25       Impact factor: 4.304

3.  Antiprotozoan activity of Brazilian marine cnidarian extracts and of a modified steroid from the octocoral Carijoa riisei.

Authors:  Juliana Quero Reimão; Alvaro Esteves Migotto; Miriam H Kossuga; Roberto G S Berlinck; André Gustavo Tempone
Journal:  Parasitol Res       Date:  2008-09-02       Impact factor: 2.289

4.  The rationale for targeting the NAD/NADH cofactor binding site of parasitic S-adenosyl-L-homocysteine hydrolase for the design of anti-parasitic drugs.

Authors:  Sumin Cai; Qing-Shan Li; Jianwen Fang; Ronald T Borchardt; Krzysztof Kuczera; C Russell Middaugh; Richard L Schowen
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2009-05       Impact factor: 1.381

5.  In vitro and in vivo biological effects of novel arylimidamide derivatives against Trypanosoma cruzi.

Authors:  Bruno Lisboa Timm; Patrícia Bernadino da Silva; Marcos Meuser Batista; Francisca Hildemagna Guedes da Silva; Cristiane França da Silva; Richard R Tidwell; Donald A Patrick; Susan Kilgore Jones; Stanislav A Bakunov; Svetlana M Bakunova; Maria de Nazaré C Soeiro
Journal:  Antimicrob Agents Chemother       Date:  2014-04-21       Impact factor: 5.191

6.  Neglected tropical diseases and vitamin B12: a review of the current evidence.

Authors:  Alexander J Layden; Kristos Täse; Julia L Finkelstein
Journal:  Trans R Soc Trop Med Hyg       Date:  2018-10-01       Impact factor: 2.184

Review 7.  Modulation of immune response in experimental Chagas disease.

Authors:  Beatriz Basso
Journal:  World J Exp Med       Date:  2013-02-20

8.  Inefficient complement system clearance of Trypanosoma cruzi metacyclic trypomastigotes enables resistant strains to invade eukaryotic cells.

Authors:  Igor Cestari; Marcel I Ramirez
Journal:  PLoS One       Date:  2010-03-16       Impact factor: 3.240

9.  Inheritance of DNA transferred from American trypanosomes to human hosts.

Authors:  Mariana M Hecht; Nadjar Nitz; Perla F Araujo; Alessandro O Sousa; Ana de Cássia Rosa; Dawidson A Gomes; Eduardo Leonardecz; Antonio R L Teixeira
Journal:  PLoS One       Date:  2010-02-12       Impact factor: 3.240

10.  Advancing drug innovation for neglected diseases-criteria for lead progression.

Authors:  Solomon Nwaka; Bernadette Ramirez; Reto Brun; Louis Maes; Frank Douglas; Robert Ridley
Journal:  PLoS Negl Trop Dis       Date:  2009-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.